Sustained virological response - Globe Thesis

Keyword [Sustained virological response] Result: 1 - 16 \| Page: 1 of 1
1.	The Analysis Of Early Virological Response And Sustained Virological Response On Chronic Hepatitis B Patients With PEG Interferon α-2a Treatment
2.	Clinical Study On The Effect Of PEG Interferon α-2a Plus Ribavirin In Chronic Hepatitis C Patients
3.	The Association Of IL28B Genetic Variation And Hepatitis C
4.	Clinical And Pathological Features And Intrahepatic Th1,Th2,Th17 And Treg T Cell Changes In Difficult-to-treat Chronic Hepatitis C
5.	Factors Associated With The Clinical Outcomes And Effectiveness To Interferon Treatment In Chronic Hepatitis C Patient
6.	The Relationship Of Interleukin 28B Genetic Polymorphisms And Interferon Resistance To Hepatitis C Virus Treatment Response
7.	A Comparison Between The Effects Of Pegylated Interferon α-2a And Ordinary Interferon α-2b In Combination With Ribavirin And An Analysis Of Predicitive Factors In Anti-viral Treatment Of Hepatitis C
8.	Association Of Rs12979860and Rs8099917Polymorphisms Near IL28b With SVR In Hepatic Allograft Recipients With HCV Recurrence Undergoing PEG-IFN/RBV Therapy: A Meta-analysis
9.	Ten-year Follow-up Outcomes And Predictive Factors Analysis Of Patients With Chronic Hepatitis C After Getting Sustained Virological Response To Pegylated Interferon And Ribavirin Therapy
10.	Clinical Significance Of T Cell Immunoglobulin And Mucin-3 In Chronic Hepatitis C Infection
11.	The Relationship Between ITPA Rs1127354 Polymorphisms And Efficacy/long-term Prognosis Of Antiviral Treatment In CHC Patients
12.	Evaluating Siglec-7 Expression As A Biomarker To Predict HBeAg Seroconversion And Sustained Virological Response Undergoing Pegylated Interferon Therapy In Chronic HBV Patients
13.	Study On Genetic Drug Resistance Polymorphism In NS5B Region Of Hepatitis C Virus
14.	Efficacy And Safety Analysis Of Different DAAs Regimens In The Treatment Of Patients With Genotype 1b Chronic Hepatitis C
15.	A Long-term Clinical Study Of Virological And Hepatic Benefits Of Patients With Chronic Hepatitis C Virus Infected After DAA Treatment
16.	Follow-up Study Of Disease Progression In Patients With Chronic Hepatitis C Treated With Antiviral Therapy
<<First <Prev Next> Last>> Jump to